期刊文献+

多西他赛Pluronic F127聚合物胶束的制备与表征 被引量:9

Preparation and characterization of docetaxel loaded pluronic F127 polymeric micelles
暂未订购
导出
摘要 目的制备多西他赛(DTX)的F127聚合物胶束,对其药剂学特征进行评价。方法薄膜分散法制备胶束,并在单因素考察的基础上,以正交试验优化处方;透射电镜观察胶束形态;粒度分布测定仪测定其粒径、粒度分布;离心过滤法测定胶束的包封率和载药量;以DTX注射液作对照,采用动态膜透析法考察载药胶束的体外释药情况。结果薄膜分散法制备的胶束呈球形或类球形,平均粒径为(30.2±2.56)nm,平均包封率为(86.66±2.46)%,平均载药量为(0.42±0.01)%;体外释放实验结果表明该胶束具有一定的缓释能力。结论该胶束制备工艺简单,成型好,包封率高,具有一定的缓释能力。 Purpose To prepare docetaxel(DTX) loaded pluronic F127 polymeric micelles and to investigate the pharmaceutical characteristics.Methods The DTX loaded polymeric micelles were prepared by film dispersion method using a nonionic surfactant pluronic F127,and based on the results of single-factor experiments,the best formulation of DTX loaded polymeric micelles were optimized by the orthogonal design.The morphology of DTX loaded polymeric micelles was observed under transmission electronic microscopy.The particle sizes and the polydispersity were measured by laser particle size analyzer.The drug loading and entrapment efficiencies were determined by centrifugation-filtration method.The in vitro release kinetics of DTX-micelles was studied by dynamic dialysis system using DTX-injection as control.Results The morphology of DTX-micelles was approximately spherical and the mean particle size was(30.2±2.56) nm.The mean entrapment efficiency and drug loading were(86.66±2.46)% and(0.42±0.01)%,respectively.These release results indicated that DTX-F127 polymeric micelles observed the sustained release capacity.Conclusion DTX-F127 polymeric micelles can be prepared easily by good morphology,high entrapment efficiency and certain restrained release capacity.
机构地区 山东大学药学院
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2011年第2期107-110,114,共5页 Chinese Journal of Biochemical Pharmaceutics
基金 由山东大学大学生创新课题资助
关键词 多西他赛 PLURONIC F127 聚合物胶束 docetaxel Pluronic F127 polymeric micelles
  • 相关文献

参考文献11

二级参考文献76

共引文献59

同被引文献98

  • 1吴先平,冯俊光,陈浩铭,程芳,张丽蓓,韦志军,陈伟才.葛根素对高血压患者围手术期心肌损伤的保护作用[J].中国中西医结合杂志,2006,26(3):255-257. 被引量:10
  • 2周细应,李卫红,何亮.纳米颗粒的分散稳定性及其评估方法[J].材料保护,2006,39(6):51-54. 被引量:29
  • 3Pazdur R, Kudelka A P, Kavanagh J J, et al. The taxoids : paclitaxel ( Taxol ) and docetaxel ( Taxotere )[J]. Cancer Treat Rev, 1993, 19(4) :351-386.
  • 4Cortes J E, Pazdur R. Docetaxel [J ]. J Clin Oncol, 1995, 13 (10) :2643-2655.
  • 5Musumeci T, Ventura C A, Giannone I, et al. PLA/PL- GA nanoparticles for sustained release of docetaxel [ J ]. Int J Pharm, 2006, 325(1-2) : 172-179.
  • 6Yokoyama M. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials [J]. Expert Opin Drug Deliv, 2010, 7(2) : 145-158.
  • 7Mu C F, Balakrishnan P, Cui F D, et al. The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel [J]. Biomaterials, 2010, 31(8): 2371-2379.
  • 8Yin Y M, Cui F D, Mu C F, et al. Docetaxel microe- mulsion for enhanced oral bioavallability: preparation and in vitro and in vivo evaluation [ J ]. J Control Release, 2009, 140(2): 86-94.
  • 9Gaucher G, Dufresne M H, Sant V P, et al. Block copol- ymer micelles: preparation, characterization and applica- tion in drug delivery [J]. J Control Release, 2005, 109 (1-3): 169-188.
  • 10ten Tije A J, Verweij J, Loos W J, et al. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy [ J ]. Clin Pharmacokinet, 2003,42 ( 7 ) : 665-685.

引证文献9

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部